Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
Behavioural Pharmacology|October 19, 2016
Aripiprazole for cocaine abstinence: a randomized-controlled trial with ecological momentary assessmentLandhing M Moran, Karran A Phillips, William J Kowalczyk, et al.Brain and Behavior|August 23, 2016
Using iPSC-derived human DA neurons from opioid-dependent subjects to study dopamine dynamicsYang Sheng, Emily Filichia, Elizabeth Shick, et al.The American Journal of Drug and Alcohol Abuse|April 12, 2018
Sex differences in daily life stress and craving in opioid-dependent patientsLandhing M Moran, William J Kowalczyk, Karran A Phillips, et al.Psychopharmacology|July 8, 2018
Before and after: craving, mood, and background stress in the hours surrounding drug use and stressful events in patients with opioid-use disorderKenzie L Preston, William J Kowalczyk, Karran A Phillips, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 7, 2017
Exacerbated Craving in the Presence of Stress and Drug Cues in Drug-Dependent PatientsKenzie L Preston, William J Kowalczyk, Karran A Phillips, et al.Psychopharmacology|July 9, 2015
Some of the people, some of the time: field evidence for associations and dissociations between stress and drug useMelody Furnari, David H Epstein, Karran A Phillips, et al.Psychopharmacology|June 9, 2017
Context and craving during stressful events in the daily lives of drug-dependent patientsKenzie L Preston, William J Kowalczyk, Karran A Phillips, et al.Drug and Alcohol Dependence|December 10, 2019
Multimodal assessment of sleep in men and women during treatment for opioid use disorderPatrick H Finan, Chung Jung Mun, David H Epstein, et al.Journal of Addiction Medicine|September 9, 2017
Perceptions of Neighborhood Mediate the Relationship Between PTSD Symptoms and Coping in a Neighborhood-Matched Substance-Using SampleSara K Hertzel, Jennifer Schroeder, Landhing M Moran, et al.Psychopharmacology|August 7, 2018
Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorderJennifer R Schroeder, Karran A Phillips, David H Epstein, et al.Pageof 6